| Structure | Chemical Name | CAS | MF |
|
ANTI-OCTN1, NOVEL, MOUSE, 20AA WITHIN CT
|
|
|
|
|
Antioxidanet DFC-34
|
|
|
|
|
ANTI-OCTN1, MOUSE, NOVEL, 20AA WITHIN CT
|
|
|
|
|
ANTIOXIDANTS(GENERAL)
|
|
|
|
|
ANTI-ONCOPROTEIN C-ERB-2, HUMAN (929-947)
|
|
|
|
|
Antioxidant G-16 (most toxic antiox)
|
61373-87-3
|
|
|
|
ANTI-OIF (AA 206-217)
|
|
|
|
|
ANTI-OSTEOPONTIN, MOUSE
|
|
|
|
|
Antioxidant PVN
|
|
H6O5VNa
|
|
Anthyridine, radical ion(1+) (9CI)
|
932039-57-1
|
C11H7N3
|
|
|
Antioxidant T502
|
|
|
|
|
Anti-ORC2 (Ab-2), Human (Mouse)
|
|
|
|
|
Anti-Orexin A (Ab-1), Human (Rabbit)
|
|
|
|
|
ANTI-ORC (AB-1), S CERVISIAE
|
|
|
|
|
ANTI-OPIOID RECEPTOR, KAPPA (C-TERMINAL) (AA 346-380)
|
|
|
|
|
ANTI-OESTROGEN RECEPTOR, BETA-, RAT, 19AA CT
|
|
|
|
Antioside
|
3981-16-6
|
C29H44O10
|
|
|
ANTI-OGT
|
|
|
|
|
ANTI-OREXIN-2 RECEPTOR, HUMAN, MOUSE, RAT
|
|
|
|
|
ANTI-OESTROGEN RECEPTOR, BETA-, HUMAN, 20AA NT
|
|
|
|
|
Antioxidant 3C
|
|
|
|
|
ANTI-OCTAMER-BINDING TRANSCRIPTION FACTOR 4
|
|
|
|
|
Antioxidant 350
|
|
|
|
|
ANTI-OREXIN A (HUMAN, BOVINE, MOUSE, RAT)
|
|
|
|
|
ANTI-OESTRADIOL (E2), 17-BETA-, HUMAN
|
|
|
|
|
Antioxidant Ble-W
|
|
|
|
|
ANTI-ONCOGENE DJ1
|
|
|
|
|
ANTI-ORGANIC ANION TRANSPORTING POLYPEPTIDE 2
|
|
|
|
|
Anti-ORC (Ab-1), S. cerevisiae (Mouse)
|
|
|
|
|
Antioxidant PPD-B
|
|
|
|
|
ANTI-OESTROGEN RECEPTOR, BETA-, RAT, 18AA CT
|
|
|
|
|
ANTI-OX7
|
|
|
|
|
ANTI-OPIOID RECEPTOR, SUBTYPE MU-MOR-1A, HUMAN, COOH TERMINUS
|
|
|
|
|
Anti-OAT4L;URAT1 (Urate Transporter 1)
|
|
|
|
|
ANTI-ONCOPROTEIN C-MET
|
|
|
|
|
ANTI-OCCLUDIN
|
|
|
|
|
ANTI-OIF (AA 127-141)
|
|
|
|
|
ANTI-OXPHOS COMPLEX I 20 KDA SUBUNIT, MOUSE IGG1
|
|
|
|
|
ANTIOXIDANTS(FORPLASTICSANDRUBBERS)
|
|
|
|
|
ANTI-OESTRADIOL-6 (E2)
|
|
|
|
|
Antioxygen and antigum inhibitor VCK-2002,high efficiency
|
|
|
|
|
Antioxidant 6225
|
|
|
|
|
Antioxidant DFC-35
|
|
|
|
|
Antioxidizing agent for copper surface
|
|
|
|
|
ANTIODORANT liquid spray
|
|
|
|
|
Antioxidant B501W
|
|
|
|
|
Antioxidant Supplement (1000×)
|
|
|
|
|
Antioxidant 1010-A
|
|
|
|
|
Antioxidant,compound
|
|
|
|
|
Antioxidant 8PPD-35,compound
|
|
|
|
|
Antioxidant 264-B
|
|
|
|
|
Antioxidant BLEE
|
|
|
|
|
Antioxidant 688
|
|
C20H28N2
|
|
|
Antioxidant TBP
|
|
|
|
|
Anti-O-GLcNAc, Anti-OGT
|
|
|
|
|
ANTI-OSTEOCALCIN PROPEPTIDE PRECURSOR 38-50, HUMAN
|
|
|
|
|
ANTI-OAT3, RAT, 16AA NEAR CYTOPLASMIC CT
|
|
|
|
|
Antioxidant 8 PPD
|
|
|
|
|
Antioxidant AM
|
|
|
|
|
ANTI-ONCOPEOREIN MYC (FUSION TAG), HUMAN, 10AA C-MYC EPITOPE
|
|
|
|
ANTI-8-OXOG
|
|
C5H3N5O2
|
|
|
Antioxidant 215
|
|
|
|
|
Antioxidants:Rd(Tmq)
|
|
|
|
|
ANTI-OCT2, RAT, 21AA FROM MID REGION
|
|
|
|
|
ANTI-OPIOID RECEPTOR, SUBTYPE MU-MOR-1B, HUMAN, COOH TERMINUS
|
|
|
|
|
Antioxidant B215, Complex
|
|
|
|
|
ANTI-OCT1, RAT, 21AA WITHIN CYTOPLASMIC CT
|
|
|
|
|
ANTI-ONCOPROTEIN N-RAS (1-18)
|
|
|
|
|
Antioxidant MB-A
|
|
|
|
|
ANTI-OSTEOCALCIN (HUMAN, 38-49)
|
|
|
|
|
ANTIOGENIN, HUMAN
|
|
|
|
|
ANTI-OREXIN-B RECEPTOR
|
|
|
|
|
ANTI-ONCOPROTEIN P53, HUMAN
|
|
|
|
|
ANTI-ONCOPROTEIN HER-2, HUMAN
|
|
|
|
|
ANTI-OTRPC4
|
|
|
|
|
Anti-Obesity Agents
|
|
|
|
|
ANTI-OR-2 (1-14)
|
|
|
|
|
ANTI-OCT-1 (AB-3) MOUSE MAB
|
|
|
|
|
Antioxidant B225, Complex
|
|
|
|
|
ANTI-ONCOPROTEIN C-JUN (320-340)
|
|
|
|
|
ANTI-OBESTATIN (HUMAN)
|
|
|
|
|
ANTI-O4
|
|
|
|
|
Antioxidant 259
|
|
C40H62O6
|
|
|
ANTIOXIDANTS(FOOD)
|
|
|
|
|
ANTI-OPOSSUM PARATHYROID HORMONE RECEPTOR
|
|
|
|
|
ANTI-OESTROGEN RECEPTOR, BETA-, HUMAN, 19AA CT
|
|
|
|
|
ANTI-8-OXOGUANINE DNA GLYCOSYLASE, MOUSE 18AA NEAR NT
|
|
|
|
|
Antioxidant ZY168
|
|
C42H63O3P
|
|
|
ANTI-OESTRIOL-3 (E3)
|
|
|
|
|
ANTI-OPIOMELANOCORTIN, PRO- (62-76), HUMAN
|
|
|
|
|
ANTHYLLISVULNERARIA
|
|
|
|
|
ANTIOXIDANTVITAMINSUPPLEMENT
|
|
|
|
|
Anti-oxidant tapanol phenol
|
|
|
|
|
ANTI-OESTRIOL-3 (E3) + SULPHATE
|
|
|
|
|
ANTI-OSTEOGENIC GROWTH PEPTIDE
|
|
|
|
|
ANTI-OXPHOS COMPLEX III 10 KDA SUBUNIT, MOUSE IGG2A
|
|
|
|
|
ANTI-OPIOID RECEPTOR, DELTA (C-TERMINAL) (AA 360-372)
|
|
|
|
|
ANTI-OSTEOCALCIN
|
|
|
|
|
ANTI-OXYTOCIN RECEPTOR
|
|
|
|
|
ANTI-OSTEOSTATIN (HUMAN)
|
|
|